Pharmacokinetics, Pharmacodynamics, And Safety Of Maraviroc (UK-427,857) In Patients With Human Immunodeficiency Virus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00643643
Recruitment Status : Completed
First Posted : March 26, 2008
Last Update Posted : November 10, 2010
Information provided by:
ViiV Healthcare

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2003
  Study Completion Date : June 2003